Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
about
The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein BaxTIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathwayBax inserts into the mitochondrial outer membrane by different mechanismsp53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARCThe use of therapeutic peptides to target and to kill cancer cells.Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2The role of peptide motifs in the evolution of a protein network.Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.BBC3 mediates fenretinide-induced cell death in neuroblastomaThe mitochondrial death pathway: a promising therapeutic target in diseasesTargeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.Rational development of a cytotoxic peptide to trigger cell death.Conformational control of Bax localization and apoptotic activity by Pro168.BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists.Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signalingBax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family membersTherapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.Natural and artificial peptide motifs: their origins and the application of motif-programming.Function and Potentials of M. tuberculosis EpitopesTherapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their functionMADD is a downstream target of PTEN in triggering apoptosis.The addressing fragment of mitogaligin: first insights into functional and structural properties.Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.Prostaglandins antagonistically control Bax activation during apoptosisIntracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein.AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis.The zebrafish bcl-2 homologue Nrz controls development during somitogenesis and gastrulation via apoptosis-dependent and -independent mechanisms.Bax, Bak and beyond - mitochondrial performance in apoptosis.Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.
P2860
Q24310440-22D9D018-4195-4F65-B599-C7B721ECA67EQ28301197-78841AD1-BFEE-4839-91D3-6C4277D4E508Q28567499-E923DF0C-0406-4742-8FD1-35DCCA928C6EQ28569720-827C6517-CFD2-480D-B94B-E4B36C7F8C3BQ30418414-1AD3441E-AA0D-4DE2-9DE3-FDD6BF48DFA6Q30493313-B3546B0B-928C-4F5B-8D99-B75021F0C6CCQ33299646-1CCA86BD-637F-492A-8741-0199BE81F338Q33991166-17295B4A-6872-45E6-8CFC-D5CFBA13C80EQ34097530-ECC667B5-D0D4-4B2D-94AD-BA63191F64A3Q34231949-9B2A9C7B-B25B-4B00-A32E-E1A326FB455DQ35831981-CC9AC0E8-E63F-4852-9C6D-2319B249E274Q36088627-C04987FE-B458-4546-843B-12D7800327D1Q36279284-5D1FB47F-D258-4E38-95E5-249197E503AFQ36321947-8AF43BF6-9D30-4942-ACAF-053F1367BD34Q36948615-47712C22-5C80-40CC-8BD5-18DFB3AA8F23Q37037631-3ECADA56-E724-4725-8774-98321AC1CABCQ37237621-CF11E07F-7136-4233-A72D-EBD933352A0DQ37594770-0BD63406-BEF9-4D23-BDB5-0C3FC4E3BD13Q37659943-1F57C945-D2C3-47E4-ABCF-579FABE32489Q38203257-DC50E3CF-E31D-494A-84B2-C08142D86CCBQ38442515-12885BAD-086D-40EF-8F02-EB7432E0DF18Q39028789-5ABFFA5E-133D-4EF3-B1E9-1D2038F3542BQ39095766-F0BB185C-E776-4617-A5E5-A45160BC3C9EQ39175091-442ADA40-75C8-43A8-97E6-3565DCF29EE8Q39617756-2CFB4E42-2520-4B32-844C-C6C2631ED2DEQ39641222-CBDB06F8-8585-4BEA-AD98-4F0FA19C7FF2Q39908819-380BDC5A-6B70-4727-A921-0E4D115A9E13Q40606386-694D79C5-E3BC-407F-AE32-2B92A9E0B346Q40625961-B8BE7BE2-F86B-4AC1-AB7E-A6C640D38AE9Q47073279-03E92911-74F1-473D-AB8E-9A2D007C1EC2Q47305952-C8E179A9-8C73-4289-95EF-3F527E18A844Q48145247-3C604861-F79C-4473-BE66-3A90F732144D
P2860
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
@en
type
label
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
@en
prefLabel
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
@en
P2093
P2860
P356
P1476
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins
@en
P2093
Abigail Hunt
Carole Moreau
François M Vallette
Gerard Evan
Khaled Meflah
Philippe Juin
P2860
P304
19426-19435
P356
10.1074/JBC.M209472200
P407
P577
2003-03-17T00:00:00Z